Real-world treatment patterns of rheumatoid arthritis in Brazil: analysis of DATASUS national administrative claims data for pharmacoepidemiology studies (2010-2020)

Article Public, Environmental & Occupational Health

Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study

Luciane C. Lopes et al.

Summary: Drug utilization research (DUR) is important for policymaking and health system strengthening. This study identified potential data sources for DUR in Latin American countries and found that accessibility is a major challenge.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Data Sources for Drug Utilization Research in Brazil-DUR-BRA Study

Lisiane Freitas Leal et al.

Summary: This study aims to identify and characterize data sources for Drug Utilization Research (DUR) in Brazil. A total of 62 data sources were identified and screened, with 38 meeting the eligibility criteria for inclusion and being fully characterized. The data sources were grouped into categories such as automated databases, Electronic Medical Records (EMR), national surveys or datasets, adverse event reporting systems, and others. Most of the data sources provided comprehensive data coverage for over 5 years and included both individual and aggregated data. However, information about population coverage was lacking.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Ophthalmology

Age-related macular degeneration and resource utilization in the Brazilian public healthcare system: a real-world retrospective study

Liane Touma-Falci et al.

Summary: The study found that Brazilian AMD patients receive fewer doses of antiangiogenic treatment than expected, and there are inequalities among regions, with patients in the Southeast and South regions having easier access to treatment from the public health system.

BMC OPHTHALMOLOGY (2021)

Add to Collection

Article Rheumatology

Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis

Karina Rossi Bonfiglioli et al.

Summary: Rheumatoid arthritis is a chronic autoimmune systemic inflammatory disease that affects patients' quality of life. New therapeutic targets like Janus kinases have emerged, with JAK inhibitors gaining importance as a highly effective treatment for RA.

ADVANCES IN RHEUMATOLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Operational Challenges in the Use of Structured Secondary Data for Health Research

Kelsy N. Areco et al.

Summary: This study describes the steps to ensure the adequacy of a secondary data set for a specific use, with data understanding and data preparation identified as the most critical steps, accounting for about 70% of the challenges. Understanding these challenges and taking appropriate actions may contribute to planning health research effectively.

FRONTIERS IN PUBLIC HEALTH (2021)

Add to Collection

Review Rheumatology

The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review

Khalid Almutairi et al.

Summary: The study aimed to determine the global population prevalence of rheumatoid arthritis (RA) from 1980 to 2019 and found a global RA prevalence estimate of 0.46%, with variations due to geographical location and study methodology. The highest RA prevalence (0.69%) was derived from studies involving linked data sources.

RHEUMATOLOGY INTERNATIONAL (2021)

Add to Collection

Article Multidisciplinary Sciences